Immuneering Announces Clinical Supply Agreement with Regeneron Pharmaceuticals to Evaluate IMM-1-104 in Combination with Libtayo® (cemiplimab)
Immuneering plans to evaluate IMM-1-104 in combination with Libtayo in patients with advanced non-small cell lung cancer in its ongoing Phase ...
Immuneering Signs Clinical Supply Agreement With Regeneron To Evaluate IMM-1-104 Plus Libtayo
Immuneering Corporation (IMRX), a clinical-stage oncology company, Thursday said it has signed a clinical supply agreement with ...
People5d
What Is the Super Bowl Logo Conspiracy? Here's Why Fans Are Convinced This Theory Accurately Predicts the Championship Teams
Fans don't think that the two colors in the Super Bowl 2025 logo — red and green — are a coincidence Skyler Caruso is a Writer and Reporter of PEOPLE Digital Entertainment. She joined PEOPLE ...
The Edge Singapore4d
Early FY2024 results show Keppel DC REIT and CICT leading the pack on new ICR rules
For FY2024, as of Feb 5, of the eight REITs that have announced either year-end or first-half results, two were able to ...
Krafton partners Kuku FM to expand BGMI universe with audiobook
South Korean gaming giant Krafton is partnering with one of its investee companies, the audio content platform Kuku FM, to ...